The Claim

Semaglutide increases the levels of the enzyme 15-PGDH, leading to enhanced degradation of prostaglandin E2 and accelerated skeletal muscle wasting.

What the research says

Challenges is higher

Challenge is ahead, but a single strong supporting study can change this.

Supports
0score
Challenges
8score

These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.

How it works
1 study reviewed
In plain English

Semaglutide raises the amount of the enzyme 15-PGDH, which breaks down prostaglandin E2 and results in faster loss of skeletal muscle mass.

See the scientific wording

Semaglutide increases levels of the enzyme 15-PGDH, which degrades prostaglandin E2 and accelerates skeletal muscle wasting.

Why this might work

When semaglutide reduces food intake, the body enters a low-nutrient state that increases the enzyme 15-PGDH. This enzyme breaks down prostaglandin E2, a molecule needed for muscle stem cells to multiply and repair damaged muscle. With less prostaglandin E2, muscle stem cells stay inactive, preventing muscle repair and causing muscle tissue to shrink over time.

Supported mechanismbased on 1 study

What the research says

1 study

  1. Study: 15-PGDH Inhibition Overcomes Muscle Regenerative Deficit Seen With GLP1-Receptor Agonist–Induced Weight Loss

    The study didn’t measure if semaglutide raises the enzyme 15-PGDH, but it did show that blocking this enzyme fixes the muscle loss caused by semaglutide — which suggests semaglutide might be making more of it, but we can’t say for sure from this study alone.

Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies

Fit Body Science verdict — we translate health claims into clear verdicts backed by peer-reviewed research.

Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.